Peereboom, D., Nabors, L. B., Kumthekar, P., Badruddoja, M., Fink, K., Lieberman, F., Phuphanich, S., Dunbar, E., Walbert, T., Schiff, D., Tran, D. D., Ashby, L. S., Butowski, N., Iwamoto, F., Lindsay, R., Bullington, J., Schulder, M., Sherman, J., Brooks, C., & Reardon, D. (n.d.). 373OResults of phase II trial of SL-701, a novel immunotherapy targeting IL-13Ra2, EphA2, and survivin, in adults with second-line recurrent glioblastoma (GBM). Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095474905.0x000048